US › Healthcare

Teladoc Inc (TDOC)

US · Healthcare · Health Information Services

$6.71+0.45%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$606.9M
Revenue YoY
-4.0%
Net profit
$-38.9M
Profit YoY
-19.1%
EPS
$-0.21
EPS estimate
$-0.24
Net margin
-6.4%

EPS came in at -0.21 against a street estimate of -0.24 — a beat of 12.5%.

Key statistics

Market cap
$1.22B
Forward P/E
303.0
P/B
0.93
Book value
$7.21
EPS (TTM)
$-0.99
52-week high
$9.89
52-week low
$4.40
50-day MA
$8.13
200-day MA
$6.89
Beta
2.10

Analyst view

Analysts rate Teladoc Inc a hold (5 buy, 19 hold, 0 sell out of 24) with an average price target of $7.76.

Shareholding

Insiders
0.70%
Institutions
82.97%

Largest institutional holders

FundStake
BlackRock Inc8.04%
Vanguard Portfolio Management, LLC6.77%
Renaissance Technologies Corp4.45%
Vanguard Capital Management, LLC4.32%
Point72 Asset Management, L.P.4.25%
Dimensional Fund Advisors, Inc.3.47%
Allianz Asset Management AG2.64%
State Street Corp2.40%

Recent filings & reports

DocumentDate
Quarterly report · Q2 20262026-07-30
Results announced · Q3 20262026-07-29
Shareholder vote results · Q2 20262026-05-21
Quarterly report · Q1 20262026-04-30
Results announced · Q2 20262026-04-29
Proxy statement · Q2 20262026-04-07
Board / officer change · Q1 20262026-03-30
Annual report FY20252026-02-26

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Teladoc Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.